Fire acupuncture for postherpetic neuropain: a multicenter randomized controlled trial

Not Applicable

Recruiting

• Conditions: Postherpetic neuralgia

• Registration Number: ITMCTR1900002624
• Lead Sponsor: The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Diagnostic and inclusion criteria
To be eligible for the study, patients had to meet all thefollowing criteria:
(1) Patients should be diagnosed with PHN (defined as persistent pain after one month from the disappearance of the herpes zoster rash);
(2) Before clinic, the skin lesions of the herpes zoster should be treated with a normal course with enough duration. The herpes should be healed, or the crust should have fallen off. There remained abnormal sensations such as heat, cold, burn-like pain, needle-like pain, the electric shock sensation or touch-induced pain, hyperalgesia, numbness, itching in affected part of skin;
(3) A pain scale of ?40mm on visual analogue scale(VAS);
(4) The age should be between 18-70 years old;
(5) No oral or external use of glucocorticoids;
(6) Patients should be able to give written informed consent for study participation, understand procedures of this study, and complete patient-reported questionnaires adequately.

Exclusion Criteria

Any person who met any of the following criteria should be excluded:
(1) The herpes zoster belonginged to a special type, such as eye zoster, ear zoster, visceral zoster, meningeal zoster, generalized zoster, etc. Those with new herpes at the time of visit should be excluded;
(2) Those who were in pregnant, confinement or lactation period;
(3) Those who were allergic to certain drugs;
(4) Those with cicatricial diathesis;
(5) Those with severe cardiovascular or cerebrovascular diseases, primary or secondary liver, kidney, hematopoiesis or immune system diseases. Those with diabetes, malignant tumor, mental diseases, diseases in connective tissue. Those with hemophilia or bleeding tendency.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
VAS;

Secondary Outcome Measures

Name	Time	Method
Pain threshold;ID Pain scale;pain scale;Mechanical allodynia, ALL;DN4 neuropathic pain scale;LANSS scale;Pricking threshold;SF-36 scale;Liver and kidney function;neuropathic pain symptoms inventory, NPSI;Ninjurin2;